CIPHER PHARMACEUTICALS INC - CPHRF

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q4 2016 · Compare: Q3 2016
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Northwest & Ethical Investments L.P. History No change 472,670 1,724 0.12% 0.13% 1 0 0.0% Q4 2016 Jul 08, 2025